MD3940F1 - Method for treating the brachial paralysis - Google Patents
Method for treating the brachial paralysisInfo
- Publication number
- MD3940F1 MD3940F1 MDA20080101A MD20080101A MD3940F1 MD 3940 F1 MD3940 F1 MD 3940F1 MD A20080101 A MDA20080101 A MD A20080101A MD 20080101 A MD20080101 A MD 20080101A MD 3940 F1 MD3940 F1 MD 3940F1
- Authority
- MD
- Moldova
- Prior art keywords
- days
- over
- homaccord
- day
- biologically active
- Prior art date
Links
Landscapes
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Inventia se refera la medicina, neurologie, pediatrie si este destinata tratamentului paraliziilor plexului brahial la nou-nascuti si sugari. Metoda, conform inventiei, consta in aceea ca se administreaza per os Bryaconeel si Nervoheel cate 1/4…1/2 pastila de 3 ori pe zi timp de 1 luna; Cinnamomum-Homaccord N, Lymphomyosot si Galium-Heel N de 3 ori pe zi cate 3…5 picaturi timp de 1 luna; subcutanat Traumeel S cate 0,4…0,8 ml zilnic in primele 3 zile, apoi peste 1 zi, Cerebrum Compositum N cate 0,4…0,8 ml peste 3 zile, Gelsemium-Homaccord cate 0,3…0,5 ml peste 2 zile, Ferrum-Homaccord cate 0,3…0,5 ml peste 3 zile, Circulo-Injeel cate 0,3…0,6 ml de 2 ori pe saptamana, la o serie de tratament de 7…10 injectii, de asemenea Coenzyme compositum si Ubichinon Compositum cate 0,3…0,5 ml o data pe saptamana, la o serie de tratament de 2…4 injectii. Totodata, preparatele mentionate se administreaza in urmatoarele puncte biologic active: T14; V11; IG 2-8, 12,15; VB21; G 5-12, 14-15; P5,9; C3-8; MC3-9; TR3-10; AP37,41,55,63,64,65,66. In fiecare punct biologic activ se introduce un singur preparat medicamentos mentionat cate 0,1…0,3 ml, care se administreaza in 3…5 puncte, totodata in fiecare zi se selecteaza diferite puncte biologic active.The invention relates to medicine, neurology, pediatrics and is intended for the treatment of paralysis of the brachial plexus in newborns and infants. The method, according to the invention, consists in the fact that Bryaconeel and Nervoheel are administered per bone 1/4… 1/2 pill 3 times daily for 1 month; Cinnamomum-Homaccord N, Lymphomyosot and Galium-Heel N 3 times a day 3 to 5 drops for 1 month; subcutaneously Traumeel S each 0.4… 0.8 ml daily for the first 3 days, then over 1 day, Cerebrum Compositum N each 0.4… 0.8 ml over 3 days, Gelsemium-Homaccord each 0.3… 0.5 ml over 2 days, Ferrum-Homaccord each 0.3 ... 0.5 ml over 3 days, Circulo-Injeel each 0.3 ... 0.6 ml 2 times a week, at a series of treatments of 7 ... 10 injections, also Coenzyme compositum and Ubichinon Compositum each 0.3 ... 0.5 ml once a week, in a series of treatments of 2 ... 4 injections. At the same time, the mentioned preparations are administered in the following biologically active points: T14; V11; IG 2-8, 12.15; VB21; G 5-12, 14-15; P5,9; 3-8; MC3-9; TR3-10; AP37,41,55,63,64,65,66. In each biologically active point, a single drug preparation mentioned 0.1 to 0.3 ml is introduced, which is given in 3 ... 5 points, at the same time, different biologically active points are selected each day.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| MDA20080101A MD3940G2 (en) | 2008-04-07 | 2008-04-07 | Method for treating the brachial paralysis |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| MDA20080101A MD3940G2 (en) | 2008-04-07 | 2008-04-07 | Method for treating the brachial paralysis |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| MD3940F1 true MD3940F1 (en) | 2009-07-31 |
| MD3940G2 MD3940G2 (en) | 2010-02-28 |
Family
ID=40941130
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MDA20080101A MD3940G2 (en) | 2008-04-07 | 2008-04-07 | Method for treating the brachial paralysis |
Country Status (1)
| Country | Link |
|---|---|
| MD (1) | MD3940G2 (en) |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| UA59569A (en) * | 2002-08-08 | 2003-09-15 | В'ячеслав Євгенович Сотниченко | Method for treating patients with paralysis of brachial plexus and device for its realization |
-
2008
- 2008-04-07 MD MDA20080101A patent/MD3940G2/en not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| MD3940G2 (en) | 2010-02-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX2011007854A (en) | Methods for treating acute myocardial infarctions and associated disorders. | |
| EA201591529A1 (en) | TREATMENT OF CHILDREN'S DEFICIENCY OF GROWTH HORMONE BY HUMAN ANALOGUES OF HORMONE GROWTH | |
| EA201101518A1 (en) | PHARMACEUTICAL COMPOSITION FOR USE IN MEDICAL AND VETERINARY OPHTHALMOLOGY | |
| MX2021002083A (en) | Insulin containing pharmaceutical compositions. | |
| MD3359F1 (en) | Method of conservative treatment of diskal hernia | |
| EA201591768A1 (en) | DOSED PREPARATIONS AS OPIOID RECEPTOR MODULATORS | |
| Chen et al. | Effects of icariin on orthodontic tooth movement in rats | |
| MD3940F1 (en) | Method for treating the brachial paralysis | |
| MD424Z (en) | Method for treatment of periodontium diseases | |
| MD3803F1 (en) | Method of treating hyperkinesia of children | |
| Giuliani et al. | Ibuprofen timing for hand surgery in ambulatory care | |
| CN102988277A (en) | Ointment for treating dermatoses such as cutaneous wart, onychomycosis and callus | |
| BR112018016817A2 (en) | pharmaceutical composition and method of treatment of growth hormone deficiency | |
| MD3927F1 (en) | Method for treating the facial paralysis | |
| MD3906F1 (en) | Method for treating the neurotic enuresis to children | |
| CN1843373A (en) | Hair growth promoting liquid | |
| BRPI0606350A2 (en) | adaptalene uses | |
| Gligorov et al. | SAFEHER: a study of assisted-and self-administered subcutaneous trastuzumab (H-SC) as adjuvant therapy in patients with early HER2-positive breast cancer (EBC) | |
| Kumari et al. | Recent advancement in topical drug delivery for psoriasis: clinical pertinence and potential market | |
| RAWAL et al. | Efficacy Of Acitretin In Management Of Acrodermatitis Continua Of Hallopeau And Consequence Of Medication Non-Adherence In Ach: A Case Report | |
| Bayão et al. | Fexinidazole and Human African Trypanosomiasis: good news for this important neglected tropical disease | |
| Wisniewski | P01-366-New treatment option in resistant schizophrenia in adolescence-case study | |
| WO2016077565A3 (en) | Methods for chronic pain management and treatment using hcg | |
| Schlessinger et al. | 53083 Efficacy and safety of a novel formulation liquid botulinum toxin, RelabotulinumtoxinA, when used for combination treatment of glabellar and lateral canthal lines | |
| Stein et al. | 49328 Effects of Titanium Dioxide Nanoparticles in Skin Wound Healing |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG4A | Patent for invention issued | ||
| KA4A | Patent for invention lapsed due to non-payment of fees (with right of restoration) | ||
| MM4A | Patent for invention definitely lapsed due to non-payment of fees |